NCT01204853View on ClinicalTrials.gov

A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Hypertension, Pulmonary
Interventions
DRUG

Sitaxentan

sitaxentan sodium 100 mg

Trial Locations (2)

Unknown

Pfizer Investigational Site, Nagoya

Pfizer Investigational Site, Shinjyuku-ku

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01204853 - A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients | Biotech Hunter | Biotech Hunter